PET of αvβ3-integrin and αvβ5-integrin expression with 18F-fluciclatide for assessment of response to targeted therapy: Ready for prime time?

Ambros J. Beer; Markus Schwaiger

doi:10.2967/jnumed.110.078568

PET of α_vβ₃-integrin and α_vβ₅-integrin expression with ¹⁸F-fluciclatide for assessment of response to targeted therapy: Ready for prime time?

Ambros J. Beer
, Markus Schwaiger

Associate Professorship of Neuroradiology

Technical University of Munich

Research output: Contribution to journal › Review article › peer-review

13 Scopus citations

Original language	English
Pages (from-to)	335-337
Number of pages	3
Journal	Journal of Nuclear Medicine
Volume	52
Issue number	3
DOIs	https://doi.org/10.2967/jnumed.110.078568
State	Published - 1 Mar 2011

Access to Document

10.2967/jnumed.110.078568

Cite this

@article{850d6f56abb540c195f485fac04f343f,

title = "PET of αvβ3-integrin and αvβ5-integrin expression with 18F-fluciclatide for assessment of response to targeted therapy: Ready for prime time?",

author = "Beer, \{Ambros J.\} and Markus Schwaiger",

year = "2011",

month = mar,

day = "1",

doi = "10.2967/jnumed.110.078568",

language = "English",

volume = "52",

pages = "335--337",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine Inc.",

number = "3",

}

TY - JOUR

T1 - PET of αvβ3-integrin and αvβ5-integrin expression with 18F-fluciclatide for assessment of response to targeted therapy

T2 - Ready for prime time?

AU - Beer, Ambros J.

AU - Schwaiger, Markus

PY - 2011/3/1

Y1 - 2011/3/1

UR - https://www.scopus.com/pages/publications/79952810411

U2 - 10.2967/jnumed.110.078568

DO - 10.2967/jnumed.110.078568

M3 - Review article

C2 - 21321266

AN - SCOPUS:79952810411

SN - 0161-5505

VL - 52

SP - 335

EP - 337

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

IS - 3

ER -

PET of αvβ3-integrin and αvβ5-integrin expression with 18F-fluciclatide for assessment of response to targeted therapy: Ready for prime time?

Access to Document

Other files and links

Cite this

PET of α_vβ₃-integrin and α_vβ₅-integrin expression with ¹⁸F-fluciclatide for assessment of response to targeted therapy: Ready for prime time?